- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07640490
Influence of Oral Probiotics on Anxiety and Depression in Adolescents After Non-cardiac and Non-gastrointestinal Surgeries: A Prospective, Double-blind, Placebo-controlled Study
June 6, 2026 updated by: Henan Provincial People's Hospital
This study intends to conduct a prospective, double-blind, randomized, controlled trial.
Adolescents aged 12-17 years old and American Society of Anesthesiologists (ASA) physical status I and II are selected as subjects.
Oral probiotics is used as intervention before surgery, vital signs data, serum IL-1, IL-6, BDNF,5-HT and other inflammatory indicators are collected before surgery and after non-cardiac and non-gastrointestinal surgeries, and the incidence and degree of anxiety and depression are evaluated after non-cardiac and non-gastrointestinal surgeries.
To determine the effect of esketamine on reducing anxiety and depression in adolescents after non-cardiac and non-gastrointestinal surgeries, and to provide an effective clinical basis for accelerating the rehabilitation of adolescents after non-cardiac and non-gastrointestinal surgeries.
Study Overview
Study Type
Interventional
Enrollment (Actual)
150
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Henan
-
Zhengzhou, Henan, China, 450000
- Henan Provincial People's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 8 years ≤ age ≤17 years;
- Patients who plan to undergo elective surgery under general anesthesia, and the operation time is 1-2 hours;
- ASA grade I-II
- The body mass index falls within the normal range, which is 18.5 - 23.9 kg/m2.
Exclusion Criteria:
- The patient has psychological disorders, including but not limited to bipolar affective disorder.
- Eating disorder
- No informed consent form
- Due to certain serious diseases, one needs to take medication for a long period of time.
- Personality disorder
- Has undergone or needs to undergo gastrointestinal surgery
- Have taken antibiotics or probiotics within the past 8 weeks
- Pure vegetarian diet
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Continuous oral administration of probiotics(Bifidobacterium Tetra-Strain Live Bacteria Tablets)
Selincon
|
Continuous oral administration of probiotics
|
|
Placebo Comparator: Take a placebo, which looks no different from a probiotic agent
|
Take a placebo, which looks no different from a probiotic agent
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety scale scores after surgery during 2 month
Time Frame: 2 months
|
Hamilton Anxiety Rating Scale (HAMA):The lower the score, the better the result
|
2 months
|
|
Depression scale scores after surgery during 2 month
Time Frame: 2 months
|
Beck Depression Inventory (BDI):The lower the score, the better the result
|
2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 2, 2025
Primary Completion (Actual)
May 2, 2026
Study Completion (Actual)
May 2, 2026
Study Registration Dates
First Submitted
May 14, 2026
First Submitted That Met QC Criteria
June 6, 2026
First Posted (Actual)
June 10, 2026
Study Record Updates
Last Update Posted (Actual)
June 10, 2026
Last Update Submitted That Met QC Criteria
June 6, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- HenanGY
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety Depression
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
International Association Psychosomatics And Health...RecruitingAnxiety | Anxiety DepressionUkraine
-
Duke Kunshan UniversityNational Natural Science Foundation of China; Kunshan Hospital of Traditional... and other collaboratorsNot yet recruitingAnxiety DepressionChina
-
University of PatrasUniversity of Bologna; Modena Health Authority; 6th Hellenic Health DistrictNot yet recruitingAnxiety DepressionGreece, Italy
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Recruiting
-
University of California, BerkeleyUniversity of California, San Francisco; University of California, IrvineRecruiting
-
Moon (Guangzhou) Biotechnology Co., Ltd.Not yet recruiting
-
Florida State UniversityNational Cancer Institute (NCI)Recruiting
-
University of AlcalaCompletedAnxiety | Depressive Symptoms | Anxiety Symptoms | Subthreshold DepressionSpain
-
University Rovira i VirgiliUniversitat de Girona; University Ramon LlullActive, not recruiting
Clinical Trials on C Group
-
Emad Eldin MohamedOctober 6 UniversityActive, not recruiting
-
Fudan UniversityRecruiting
-
Kafrelsheikh UniversityActive, not recruitingPulmonary Dysfunction | Spastic DiaplegiaEgypt
-
Firat UniversityRecruiting
-
University Hospital, BordeauxTerminated
-
Cairo UniversityPrince Sultan Cardiac Center, Adult Cardiology Department.Not yet recruitingCardiac Surgery | Echocardiography, TransesophagealSaudi Arabia
-
Cairo UniversityCompleted
-
Zagazig UniversityCompleted
-
University of Massachusetts, WorcesterNational Institute of Nursing Research (NINR)CompletedHepatitis cUnited States
-
VA Office of Research and DevelopmentCompletedStress Disorders, Post Traumatic | TrustUnited States